Contract notice: Pharmaceutical products

• Country: Denmark
• Summary: Contract notice: Pharmaceutical products
• DKT Ref No: 42644348
• Deadline: 19 Jun 2021
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 206404-2020
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Object of the contract
  Pharmaceutical products
  
  Description: Contract notice: Pharmaceutical products
  
  Authority Type: Body governed by public law
  Contact Nature: Supplies
  Procedure: Open procedure
  Document: Contract notice
  Regulation: European Union, with participation by GPA countries
  Award criteria: Lowest price
  CPV code: 33600000,33600000,33600000
  CPV Description: Pharmaceutical products.
  Amgros 2021-1,801.a.
  Amgros is a partnership with the 5 regions as stakeholders. With a view to supplying the stakeholders` hospital pharmacies with medicines and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicines specified in section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowthe funds for the hospital pharmacists for Amgros I / S` purchase price with a supplement. Framework agreements are entered into without purchase and the hospital pharmacies in the regions are not obliged to use Amgros` framework agreements.
  ATC Code: B02BA01,
  Generic name: Phytomenadione,
  Dispensing form: Tablets,
  Strength: 10 mg,
  Unit value: 20 mg,
  Quantity in units: 5 750.
  The drugs listed above are offered independently by the drugs under the other tender numbers.
  Each tender number is considered. for an independent part agreement. A supplier will thus be able to choose to tender for one, more or all of the tender numbers, and the allocation will be made separately for eachyour single tender number. Reference is made to the terms of the contract, including the submission of tenders under the individual contract numbers. The suppliers must match this. The reason for this is that these are medicines for patient treatment at the opublic hospitals where the patient`s needs must be met. For a more detailed description, see section. VI.3, clause no. 3.6 and the framework agreement clause. 2. The medicinal products must have a marketing authorization valid for Denmark no later than 1 September 2020 at. 12.00. Furthermore, at the time of the expiry of the tender period and during the duration of the framework agreement, the supplier must be authorizedFor suppliers, who wish to submit a tender, must use the standard European Common Procurement Document (ESPD) standard form to declare the mandatory exclusion grounds in -- 135-136 of the Procurement Act. (Act No. 1564 of 15.12.2015, as amended). Details on completion and applicationsee of the ESPD in the tender process can be found in the guide prepared by Amgro on this and in the Competition and Consumer Agency`s "Guide to the single European tender document". The winning supplier (s) which Amgros intends to award to the Framework Agreement must, before the award, have made available to Amgros documentation as regards the compulsory exclusion grounds,cf. -- 152 - 153 of the Procurement Act. Amgros cannot exclude a supplier that is covered by one or more of the compulsory grounds for exclusion in -- 135-136 of the Procurement Act, provided that the supplier can provide sufficient evidence that the supplier is in fact reliable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a "self-cleaning" process, as long as it is dulle be relevant.
  No information required. II.2.3 Please note that a list of places of delivery is available on Amgros` supplier and supply portal:
  https: //levportal.amgros.dk
  The list is updated on an ongoing basis, as there are slight changes. II.2.4 it should be noted that Amgros has considered whether the subdivision can be further subdivided. Amgros has realized thatthis is not the case on the basis of considerations of economies of scale that will not be realized by a further breakdown as well as costs and patient safety considerations related to the subsequent contract and drug handling. II.1.5 and par. II.2.6. II.1.5 is the total value indicated for all the tender numbers (partphthalate) for the duration of the framework agreement incl. possibility of extension, cf. II.2.7. In par. II.2.6 is the listed value for each tender number incl. option for extension specified, cf. II.2.7. It should also be noted that the quoted value is calculated on the basis of the AIP (list price) for the specific packages which form the basis of the stated "quantity in units" in paragraph. II.2.4 and thatCtic purchases may therefore differ materially therefrom, cf. II.2.4, the terms of the contract. 3.6 and the framework agreement clause. 2.
  Questions about the tender documents must be submitted in the tender system, cf. the terms of the tender terms and conditions. There may be some processing days associated with user creationotherwise, it is incumbent on any bidders to ensure this in good time. Reference is made to information related to the tendering system, including the user`s guide. IV.2.4 it should be noted that some parts of the offer may also be in English. Please refer to clause no. 4.1. Note that electronic invoicing is required
  Internet address (URL): http://www.amgros.dk
• Documents:

 Tender Notice